These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30251907)

  • 1. Emerging drugs for focal epilepsy.
    Mula M
    Expert Opin Emerg Drugs; 2018 Sep; 23(3):243-249. PubMed ID: 30251907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future pharmacotherapy options for drug-resistant epilepsy.
    Elkommos S; Mula M
    Expert Opin Pharmacother; 2022 Dec; 23(18):2023-2034. PubMed ID: 36154780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational new drugs for focal epilepsy.
    Mula M
    Expert Opin Investig Drugs; 2016; 25(1):1-5. PubMed ID: 26535466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for focal epilepsy.
    Mula M
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):87-95. PubMed ID: 23176519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging drugs for partial onset seizures.
    Nasreddine W; Beydoun A; Atweh S; Abou-Khalil B
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):415-31. PubMed ID: 20476851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational small molecules in phase II clinical trials for the treatment of epilepsy.
    Greco M; Varriale G; Coppola G; Operto F; Verrotti A; Iezzi ML
    Expert Opin Investig Drugs; 2018 Dec; 27(12):971-979. PubMed ID: 30408428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.
    Campos MS; Ayres LR; Morelo MR; Marques FA; Pereira LR
    Pharmacotherapy; 2016 Dec; 36(12):1255-1271. PubMed ID: 27779771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A resurging boom in new drugs for epilepsy and brain disorders.
    Younus I; Reddy DS
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):27-45. PubMed ID: 28956955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).
    Bialer M; Johannessen SI; Levy RH; Perucca E; Tomson T; White HS
    Epilepsia; 2017 Feb; 58(2):181-221. PubMed ID: 28111749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.
    Russo E; Citraro R; Mula M
    Expert Opin Drug Discov; 2017 Nov; 12(11):1169-1178. PubMed ID: 28829199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brivaracetam for the treatment of epilepsy.
    Schulze-Bonhage A
    Expert Opin Pharmacother; 2011 Aug; 12(12):1959-66. PubMed ID: 21682662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiepileptic drugs on interictal epileptiform discharges in focal epilepsies: an update on current evidence.
    Guida M; Iudice A; Bonanni E; Giorgi FS
    Expert Rev Neurother; 2015; 15(8):947-59. PubMed ID: 26162283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Main factors determining the choice of antiepileptic drugs in a polytherapy regime in adult patients and specifics of the treatment of focal epilepsy with some new medications].
    Lebedeva AV; Kovaleva IIu; Khomutov VE; Kaĭmovskiĭ IL; Mutaeva RSh
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 2):35-43. PubMed ID: 22500331
    [No Abstract]   [Full Text] [Related]  

  • 14. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
    Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
    Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic Drugs in Clinical Development: Differentiate or Die?
    Zaccara G; Schmidt D
    Curr Pharm Des; 2017; 23(37):5593-5605. PubMed ID: 28799516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures.
    Rektor I
    Expert Opin Pharmacother; 2013 Feb; 14(2):225-35. PubMed ID: 23259931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.
    Banach M; Borowicz KK; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):639-48. PubMed ID: 25740561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.
    Willems LM; Zöllner JP; Paule E; Schubert-Bast S; Rosenow F; Strzelczyk A
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):309-324. PubMed ID: 29285947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perampanel for epilepsy with partial-onset seizures: a pharmacokinetic and pharmacodynamic evaluation.
    Schulze-Bonhage A
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1329-37. PubMed ID: 26111428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
    Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.